MCFT Earnings

MCFT reported its FY2026Q2 earnings on 2026-02-05, showcasing a revenue of 0.00 against an estimate of 69.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.12 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following MCFT's FY2026Q2 earnings announcement on 2026-02-05, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, MCFT's stock price tends to shift by an average of +2.36% in the 10 days leading up to earnings and -1.56% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate MCFT’s annual revenue to reach 69.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -0.06% and EPS estimates Revise Upward by 3.72% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between MCFT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were Revise Downward by -0.06%, while EPS estimates moved Revise Upward by 3.72% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, MCFT's stock price typically moves by +2.36% in the 10 days before its earnings and -1.56% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 0.00 and revenue of 69.00M.

The company reported strong financial performance with increased net sales, improved gross margin, and a significant rise in adjusted net income and EBITDA. The share repurchase program positively impacted EPS, and the company has no debt with strong liquidity. Despite market uncertainties and competitive pressures, the company gained market share and maintained optimistic guidance. The planned product launches and share repurchase plans further support a positive outlook. However, the lack of detailed responses on leverage management and macroeconomic impacts tempers the sentiment slightly.